Close

Sunshine Heart (SSH) Acquires Baxter's (BAX) Aquadex Product Line; Enters New Credit Facility

Go back to Sunshine Heart (SSH) Acquires Baxter's (BAX) Aquadex Product Line; Enters New Credit Facility

Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank

August 8, 2016 5:30 AM EDT

EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ: SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE: BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

Aquadex is an important... More